BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2168042)

  • 1. [Usefulness of bronchoscopic examination during the treatment of small cell carcinoma of the lung].
    Zajaczkowska J; Wiatr E; Szymańska D
    Pneumonol Pol; 1990; 58(4-5):199-204. PubMed ID: 2168042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment.
    Hiraki A; Ueoka H; Yoshino T; Chikamori K; Onishi K; Kiura K; Bessho A; Mimoto J; Date H; Ando A; Shimizu N; Harada M
    Oncol Rep; 1999; 6(1):75-80. PubMed ID: 9864405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of bronchoscopy in the early phase of chemotherapy in patients with small cell lung carcinoma for assessment of tumor regression and prognosis].
    Wiatr E; Pirozyński M; Bestry I; Szymańska D; Załeska J
    Pneumonol Alergol Pol; 1993; 61(9-10):439-44. PubMed ID: 8111318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of emergency cytological studies in bronchoscopic diagnosis of pulmonary cancer].
    Murav'eva IA; Sokolov VV
    Khirurgiia (Mosk); 1989 May; (5):7-10. PubMed ID: 2544766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Local efficiency of percutaneous radiotherapy in lung cancer. Analysis of 215 repeated bronchoscopies in relation to applied radiation dosage].
    Schwegler N; Vrh N; Kern T; Notter M; Frey M; Grossenbacher M; Hausmann M; Pfenninger T; Ragaz A; Schmid R; Siebenschein R; Keller R
    Strahlenther Onkol; 1996 Feb; 172(2):81-90. PubMed ID: 8669049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic cranial irradiation in limited-stage small-cell lung cancer: a retrospective analysis.
    Alshehadat S; Sahmoun AE
    Clin Adv Hematol Oncol; 2004 Jun; 2(6):397-400. PubMed ID: 16163213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of fibrobronchoscopy in the therapeutic evaluation of small-cell pulmonary carcinoma].
    Xaubet A; Marín A; Millá A; Sasal M; Solans M; Estapé J; Agustí-Vidal A
    Med Clin (Barc); 1983 Dec; 81(20):895-7. PubMed ID: 6319837
    [No Abstract]   [Full Text] [Related]  

  • 8. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
    Schneider J; Philipp M; Salewski L; Velcovsky HG
    Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fiber bronchoscopic semeiotics and the morphologic diagnosis of small-cell lung cancer].
    Nurguzhaev KS
    Grudn Khir; 1986; (6):60-2. PubMed ID: 3026931
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC; McCrystal MR; Christmas TI
    N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of surgery for small cell lung cancer -- response to induction chemotherapy predicts survival.
    Nakamura H; Kato Y; Kato H
    Thorac Cardiovasc Surg; 2004 Aug; 52(4):206-10. PubMed ID: 15293157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quality of life of patients with small cell lung cancer can be improved by treatment with cytostatic agents].
    Bergman B
    Lakartidningen; 1992 May; 89(19):1681-5. PubMed ID: 1315895
    [No Abstract]   [Full Text] [Related]  

  • 13. Bronchogenic carcinoma. A study of 109 cases.
    Jain NK; Madan A; Sharma TN; Agnihotri SP; Saxena A; Mandhana RG
    J Assoc Physicians India; 1989 Jun; 37(6):379-82. PubMed ID: 2556362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of imatinib in patients with small cell lung cancer.
    Johnson BE; Fischer T; Fischer B; Dunlop D; Rischin D; Silberman S; Kowalski MO; Sayles D; Dimitrijevic S; Fletcher C; Hornick J; Salgia R; Le Chevalier T
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5880-7. PubMed ID: 14676110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topotecan in small cell lung cancer.
    Schiller JH
    Semin Oncol; 1997 Dec; 24(6 Suppl 20):S20-27-S20-33. PubMed ID: 9425958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group study.
    Christodolou C; Pavlidis N; Samantas E; Fountzilas G; Kouvatseas G; Pagdatoglou K; Palamidas F; Nikolaidis C; Angelidou M; Kalofonos HP; Kosmidis P; Skarlos DV
    Anticancer Res; 2002; 22(6B):3749-57. PubMed ID: 12552988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of surgery in the treatment of small cell lung cancer].
    Puma F; Urbani M; Santoprete S; Ricci F; Sanguinetti A; Vinci D; Ottavi P; Porcaro G; Daddi G
    Minerva Endocrinol; 2001 Dec; 26(4):247-53. PubMed ID: 11782710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer].
    Bozóky G; Ruby E; Góhér I; Gábor G; Mohos A; Lengyel M
    Orv Hetil; 2005 Jul; 146(27):1433-8. PubMed ID: 16089103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
    Kawasaki M; Nakanishi Y; Kuwano K; Yatsunami J; Takayama K; Hara N
    Clin Cancer Res; 1997 Jul; 3(7):1195-200. PubMed ID: 9815799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer.
    Badzio A; Kurowski K; Karnicka-Mlodkowska H; Jassem J
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):183-8. PubMed ID: 15200999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.